Form D · Pharmaceuticals
Dynamis Pharmaceuticals, Inc.
Jenkintown, PA · CIK 0001708606
Offering snapshot reported Aug 30, 2018 · SEC filing
- Reported sold
- $458K Offering amount: $458K
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $2K Reported outside-investor minimum
- First sale
- Aug 16, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 30, 2018 | Initial | $457,993 | No comparison | 16 | SEC filing |
| Jun 13, 2018 | Amendment | $539,000 | $50,000vs Apr 25, 2018 | 15 | SEC filing |
| Apr 25, 2018 | Amendment | $489,000 | $85,000vs Jun 21, 2017 | 15 | SEC filing |
| Jun 21, 2017 | Initial | $404,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-320408
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Aug 30, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Smith | Director, Executive |
| Annette Tobia | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
261 Old York Road Suite 427
Jenkintown, PA, 19046
Jenkintown, PA, 19046